Investigational pill was well-tolerated and doesn't come with food or water restrictions

Novel Once-Daily Pill Delivers Positive Blood Glucose and Weight Reduction Results

Investigational pill was well-tolerated and doesn't come with food or water restrictions

AstraZeneca advances oral GLP-1 elecoglipron to Phase 3 following strong weight loss & diabetes data at ADA 2026. Get the trial details.

Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.Jump to contentThank you for registeringPlease refresh the page or…